查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2100093

蛋白質工程實驗室自動化市場－2026-2032年全球市場預測

Lab Automation in Protein Engineering Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，蛋白質工程實驗室自動化市場將成長至 54.8 億美元，複合年成長率為 7.09%。

主要市場統計數據
基準年 2025 33.9億美元
預計年份：2026年 36.2億美元
預測年份：2032年 54.8億美元
複合年成長率 (%) 7.09%

蛋白質工程領域的實驗室自動化正在改變蛋白質的設計、建造、測試方式，以及從中獲得的洞見在治療、診斷、工業生物催化、農業和合成生物學等領域的應用方式。該領域融合了自動化液體處理、高效能篩檢、機器人樣品製備、微流體技術、實驗室資訊管理系統、新一代定序、質譜工作流程、雲端連接資料基礎設施和電腦輔助蛋白質設計。這些技術的結合降低了人為操作的差異性，提高了實驗的可重複性，並加速了蛋白質的迭代最佳化。

隨著生物製藥、酵素工程、抗體發現、基因和細胞療法開發以及精準醫療研究的複雜性日益增加，對自動化蛋白質工程工作流程的需求也日益成長。實驗室正從孤立的儀器轉向支援封閉回路型實驗的互聯互通、數據豐富的生態系統。在這種模式下，自動化平台產生海量實驗資料集，分析系統評估蛋白質的功能和穩定性，計算工具則識別下一步測試的最佳變體。因此，實驗室自動化不再只是被視為提高效率的工具，而是被視為一種策略能力，能夠提升整個蛋白質設計流程的研究效率、數據品質、可追溯性和決策水準。

實驗室自動化領域的變革

隨著實驗室從依賴研究人員的手動實驗轉向自動化、整合的主導，蛋白質工程領域正在經歷一場結構性變革。傳統的蛋白質設計通常依賴於順序實驗、有限的樣品處理能力以及勞動密集的檢測操作。如今，自動化液體處理系統、聲波分液系統、菌落挑取儀、盤式分析儀、自動化培養箱和機械臂設備的出現，使得研究人員能夠以更高的準確性和一致性處理大規模變體文庫。

人工智慧的累積影響

人工智慧正透過改善實驗設計的優先排序、執行和結果解讀方式，對蛋白質工程領域的實驗室自動化產生累積影響。人工智慧驅動的蛋白質建模、基於機器學習的誘導進化、結構預測、序列-功能映射和生成式設計工具，正在幫助研究人員將龐大的蛋白質序列空間縮小到可透過實驗檢驗的變體集合。這減輕了濕實驗室篩檢的負擔，同時提高了所選候選物展現理想特性的機率，例如更高的結合親和性、更佳的熱穩定性、更強的觸媒活性、改變的特異性或更佳的可生產性。

蛋白質工程自動化方面的關鍵區域見解

在亞太地區，對生物技術、生物製藥製造、基因組學和學術生命科學基礎設施的持續投資正推動蛋白質工程實驗室自動化技術的快速發展。該地區各國正在拓展其在生物製藥開發、生物相似藥、酶工程和合成生物學方面的能力，從而催生了對自動化液體處理、高性能篩檢和整合數據平台的需求。中國、日本、韓國、印度、澳洲和新加坡尤其積極建構將計算生物學與自動化濕實驗室實驗結合的研究生態系統。

團體對研究和經濟聯盟的關鍵見解

北約成員國，特別是那些擁有先進生命科學和國防相關研究基礎設施的國家，日益重視生物技術韌性、生物安全和快速反應。自動化蛋白質工程工作流程可以支援應對措施開發、病原體研究、診斷和生物製造方面的準備工作。對安全資料系統、可重複研究和分散式科學研究能力的重視，與更廣泛的健康安全和技術準備的考量相一致。

各國在蛋白質工程實驗室自動化方面的關鍵見解

中國正透過投資生物製藥創新、合成生物學、基因組學和高性能研究基礎設施，迅速提升其自動化蛋白質工程能力。美國在實驗室自動化、人工智慧驅動的蛋白質設計、合成生物學和高性能篩檢的整合方面處於主導，並積極參與生技藥品發現、酶工程、疫苗研究和先進療法開發。日本在機器人技術、精密測量儀器、結構生物學和生物製造方面擁有成熟的科學基礎，並在自動化工程和蛋白質科學之間建立了牢固的合作關係。

業界領導者使用的實用建議

產業領導者應優先考慮能夠兼顧科學目標、資料完整性、工作流程可擴展性和長期互通性的自動化策略。首要任務是全面了解蛋白質工程的整個生命週期，從序列設計和DNA組裝到表達、純化、檢測方法開發、表徵和數據分析。這有助於識別瓶頸環節，從而最大限度地發揮自動化在營運和研究方面的價值。

調查方法

評估蛋白質工程實驗室自動化的可靠調查方法需要結合二手資料研究、專家檢驗以及對科學、技術和監管趨勢的系統分析。二手資料研究應包括對同行評審文獻、專利出版物、監管指南、公共資助公告、技術標準、會議期刊以及與自動化實驗室工作流程、蛋白質設計、高性能篩檢和人工智慧驅動的生物技術相關的機構報告的審查。

結論

蛋白質工程領域的實驗室自動化正成為現代生物技術的基本能力，它能夠加快實驗速度、提高實驗可重複性、增強數據可追溯性並提高蛋白質最佳化效率。隨著蛋白質設計挑戰日益複雜，實驗室正在部署整合系統，將機器人、高性能檢測、實驗室資訊學和人工智慧驅動的設計工具結合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：蛋白質工程實驗室自動化市場：依組件分類

  • 硬體
    • 液體處理系統
    • 機器人系統
    • 自動化工作站
    • 儲存系統
    • 檢測和分析設備
      • 分光光度計
      • 層析法系統
      • 質譜系統
      • 流式細胞技術系統
    • 微流體系統
  • 軟體
    • 實驗室資訊管理系統
    • 電子實驗記錄本
    • 調度和監控軟體
  • 服務
    • 安裝服務
    • 維護服務
    • 培訓和諮詢服務

第8章：蛋白質工程實驗室自動化市場：依蛋白質類型分類

  • 重組蛋白
  • 單株抗體
  • 酵素
  • 胜肽
  • 融合蛋白
  • 膜蛋白

第9章：蛋白質工程實驗室自動化市場：依技術分類

  • 聲學液體處理
    • 壓電系統
    • 超音波系統
  • 磁珠分離
    • 順磁性珠子
    • 超順磁性珠子
  • 微流體系統
    • 連續流系統
    • 基於液滴的系統

第10章：蛋白質工程實驗室自動化市場：依自動化程度分類

  • 全自動
  • 半自動
  • 手動輔助

第11章：蛋白質工程實驗室自動化市場：依部署模式分類

  • 現場
  • 基於雲端的
  • 混合

第12章：蛋白質工程實驗室自動化市場：依應用領域分類

  • 酵素工程
    • 定向演化
    • 理性設計
  • 高效能篩檢
    • 先導化合物的鑑定
    • 先導藥物最適化
  • 蛋白質表現和純化
    • 層析法
    • 過濾
  • 結構分析
    • 核磁共振
    • X光晶體結構分析

第13章：蛋白質工程實驗室自動化市場：依最終用戶分類

  • 學術研究機構
  • 生技公司
  • 受託研究機構
  • 製藥公司

第14章：蛋白質工程實驗室自動化市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第15章：蛋白質工程實驗室自動化市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第16章：蛋白質工程實驗室自動化市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第17章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Agilent Technologies, Inc
  • Amgen Inc
  • Automata Technologies
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc
  • Bruker Corporation
  • Codexis Inc
  • Danaher Corporation
  • Eppendorf SE
  • F Hoffmann-La Roche Ltd
  • Formulatrix Inc
  • General Electric Company
  • GenScript BIoTech Corporation
  • Gilson Inc
  • Hamilton Company
  • HighRes Biosolutions
  • Hudson Robotics Inc
  • Lonza Group AG
  • Merck Healthcare KGaA
  • Novo Nordisk AS
  • PerkinElmer Inc
  • QIAGEN NV
  • Revvity Inc
  • Sangamo Therapeutics Inc
  • Siemens Healthineers AG
  • Takara Bio Inc
  • Tecan Group Ltd
  • Thermo Fisher Scientific Inc
  • Waters Corporation
  • Zinsser North America
Product Code: MRR-742BD518044A

The Lab Automation in Protein Engineering Market is projected to grow by USD 5.48 billion at a CAGR of 7.09% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.39 billion
Estimated Year [2026] USD 3.62 billion
Forecast Year [2032] USD 5.48 billion
CAGR (%) 7.09%

Lab automation in protein engineering is reshaping how research teams design, build, test, and learn from proteins used in therapeutics, diagnostics, industrial biocatalysis, agriculture, and synthetic biology. The field combines automated liquid handling, high-throughput screening, robotic sample preparation, microfluidics, laboratory information management systems, next-generation sequencing, mass spectrometry workflows, cloud-connected data infrastructure, and computational protein design. Together, these technologies reduce manual variability, improve experimental reproducibility, and accelerate iterative protein optimization.

Demand for automated protein engineering workflows is being reinforced by the growing complexity of biologics, enzyme engineering, antibody discovery, gene and cell therapy development, and precision medicine research. Laboratories are increasingly moving from isolated instruments toward connected, data-rich ecosystems that support closed-loop experimentation. In this model, automated platforms generate large experimental datasets, analytical systems characterize protein function and stability, and computational tools identify the next best variants to test. As a result, lab automation is no longer viewed only as a productivity tool; it has become a strategic capability for improving scientific throughput, data quality, traceability, and decision-making across protein design pipelines.

Transformative Shifts in the Lab Automation Landscape

The protein engineering landscape is undergoing a structural transformation as laboratories shift from manual, researcher-dependent experimentation to integrated automation-driven workflows. Traditional protein design often relied on sequential experimentation, limited sample throughput, and labor-intensive assay execution. Today, automated liquid handlers, acoustic dispensing systems, colony pickers, plate readers, automated incubators, and robotic arms enable researchers to process large variant libraries with improved precision and consistency.

A major shift is the convergence of biology, automation engineering, and informatics. Protein engineering teams increasingly require interoperable platforms capable of managing DNA assembly, expression screening, purification, biophysical characterization, and functional testing within a unified workflow. The adoption of standardized data capture, electronic lab notebooks, laboratory execution systems, and laboratory information management systems is strengthening compliance, auditability, and reproducibility.

Another transformative change is the emergence of miniaturized and parallelized experimentation. Microplate-based workflows, droplet microfluidics, and nanoliter-scale assays help reduce reagent consumption while increasing experimental density. This is particularly important for directed evolution, antibody affinity maturation, enzyme optimization, and protein stability studies where large variant libraries must be evaluated under controlled conditions. The shift toward modular and flexible automation is also enabling laboratories to scale capabilities without fully replacing existing infrastructure, supporting both academic research environments and highly regulated biomanufacturing development settings.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is having a cumulative impact on lab automation in protein engineering by improving how experimental designs are prioritized, executed, and interpreted. AI-enabled protein modeling, machine learning-guided directed evolution, structure prediction, sequence-function mapping, and generative design tools are helping researchers narrow vast protein sequence spaces into experimentally testable variant sets. This reduces the burden on wet-lab screening while improving the probability that selected candidates exhibit desired traits such as higher binding affinity, improved thermostability, enhanced catalytic activity, altered specificity, or better manufacturability.

The most significant impact emerges when AI is connected directly with automated experimentation. Closed-loop protein engineering systems combine algorithmic design with robotic execution and automated analytical feedback. In these workflows, machine learning models propose variants, automated platforms construct and test them, and the resulting performance data are fed back into the model for the next cycle of optimization. This cycle supports faster learning from each experiment and helps laboratories move beyond brute-force screening toward data-efficient engineering.

AI also strengthens quality control and operational reliability in automated laboratories. Computer vision can support colony selection, assay monitoring, and anomaly detection, while predictive analytics can identify instrument drift, batch effects, and outlier data. Natural language processing and semantic data tools are improving access to historical experimental records. However, the value of AI depends heavily on curated datasets, standardized metadata, assay consistency, and robust governance. Laboratories that invest in high-quality data infrastructure are better positioned to translate AI from computational promise into practical protein engineering productivity.

Key Regional Insights for Protein Engineering Automation

Asia-Pacific is advancing rapidly in lab automation for protein engineering due to sustained investments in biotechnology, biopharmaceutical manufacturing, genomics, and academic life science infrastructure. Countries across the region are expanding capabilities in biologics development, biosimilars, enzyme engineering, and synthetic biology, creating demand for automated liquid handling, high-throughput screening, and integrated data platforms. China, Japan, South Korea, India, Australia, and Singapore are particularly active in building research ecosystems that combine computational biology with automated wet-lab experimentation.

Europe demonstrates strong demand for reproducible, sustainable, and regulation-ready laboratory automation in protein engineering. The region's focus on advanced therapies, industrial biotechnology, green chemistry, and food biotechnology supports automated workflows for protein characterization, enzyme optimization, and biologics development. Data governance, interoperability, research collaboration, and laboratory sustainability are major priorities, with automation increasingly deployed to reduce waste, improve traceability, and support standardized scientific outputs.

North America remains a highly mature environment for lab automation adoption, supported by deep biotechnology research capacity, advanced therapeutic discovery programs, strong translational science networks, and established regulatory expectations for data integrity. Automated protein engineering workflows are widely used across antibody discovery, enzyme design, vaccine research, cell therapy development, and bioprocess optimization. The region's strength lies in its integration of robotics, AI-enabled design, cloud-based laboratory informatics, and advanced analytical instrumentation.

Latin America is gradually increasing automation adoption as research institutes, diagnostic laboratories, and biopharmaceutical producers modernize infrastructure. Brazil and Mexico are leading regional activity in biotechnology research, vaccine production, agricultural biotechnology, and industrial enzyme applications. Adoption is often shaped by funding availability, import dependencies, skilled workforce development, and the need for scalable systems that can support both research and quality-controlled production environments.

Africa presents a developing but important landscape for lab automation in protein engineering, particularly in public health research, infectious disease diagnostics, vaccine research, agricultural biotechnology, and capacity-building initiatives. Adoption varies significantly across countries and institutions, with infrastructure, workforce training, reagent supply chains, and funding continuity influencing implementation. Automated and semi-automated laboratory systems can help strengthen reproducibility and throughput where regional research networks are expanding molecular biology and protein analysis capabilities.

The Middle East is developing biotechnology and precision medicine capabilities as part of broader health innovation and research diversification strategies. Investments in genomics, biomedical research centers, and advanced diagnostics are supporting interest in automated laboratory platforms. While protein engineering automation is still emerging in several markets, demand is expected to align with national priorities in healthcare resilience, biotechnology localization, and academic-industry collaboration.

Key Group Insights Across Research and Economic Alliances

NATO member countries, particularly those with advanced life science and defense-related research infrastructure, are increasingly focused on biotechnology resilience, biosecurity, and rapid response capabilities. Automated protein engineering workflows can support countermeasure development, pathogen research, diagnostics, and biomanufacturing preparedness. The emphasis on secure data systems, reproducible research, and distributed scientific capacity aligns with broader interests in health security and technological readiness.

G7 countries are highly influential in the development and deployment of automated protein engineering platforms because of their advanced research ecosystems, strong regulatory frameworks, and leadership in therapeutic innovation. Laboratories across these economies use automation to support antibody discovery, enzyme engineering, vaccine development, structural biology, and analytical characterization. The group's emphasis on research quality, data integrity, and advanced manufacturing strengthens the role of automation in both discovery and process development.

BRICS countries represent a diverse but strategically important group for lab automation in protein engineering. China and India are expanding biopharmaceutical and synthetic biology capabilities, Brazil is active in agricultural biotechnology and biologics-related research, Russia maintains scientific activity in molecular biology and biotechnology, and South Africa supports biomedical and infectious disease research networks. Across BRICS economies, automation adoption is influenced by domestic manufacturing ambitions, research funding, public health priorities, and the need to improve laboratory reproducibility.

The European Union is a strong adopter of automation-enabled protein engineering due to its integrated research programs, regulatory emphasis on data integrity, and focus on advanced biotechnology. EU laboratories prioritize interoperable systems, standardized workflows, sustainable laboratory practices, and secure data management. Automation supports research in biologics, enzymes, synthetic biology, food proteins, and industrial bioprocesses, while cross-border collaboration encourages harmonized laboratory practices.

ASEAN is becoming increasingly relevant in lab automation for protein engineering as member economies invest in biomedical research, biomanufacturing, diagnostics, and food biotechnology. Singapore serves as a regional hub for advanced life science research and automation-intensive workflows, while other ASEAN countries are expanding laboratory capacity for applied biotechnology, vaccine research, and industrial enzyme applications. The region's growth in contract research, healthcare innovation, and academic collaborations supports demand for scalable and modular automation platforms.

The GCC is building momentum through investments in healthcare innovation, genomics, precision medicine, and research infrastructure. Lab automation adoption is closely tied to national strategies that emphasize scientific diversification, advanced diagnostics, and local biomedical capabilities. Protein engineering applications are still developing, but automated systems are increasingly relevant for translational research, biobanking, molecular testing, and future biologics-related capabilities.

Key Country Insights for Lab Automation in Protein Engineering

China is rapidly scaling automated protein engineering capabilities through investments in biopharmaceutical innovation, synthetic biology, genomics, and high-throughput research infrastructure. The United States leads in the integration of lab automation, AI-driven protein design, synthetic biology, and high-throughput screening, with strong activity in biologics discovery, enzyme engineering, vaccine research, and advanced therapeutics. Japan has a mature scientific base in robotics, precision instrumentation, structural biology, and biomanufacturing, creating strong alignment between automation engineering and protein science.

India is expanding its role in biologics, vaccines, biosimilars, enzymes, and computational biology, with automation supporting quality, scalability, and faster experimental cycles. Germany emphasizes precision engineering, industrial biotechnology, bioprocess development, and analytical rigor, making it a key environment for high-quality automated protein characterization and enzyme optimization. The United Kingdom has a strong protein science and synthetic biology ecosystem, supported by advanced academic research, translational medicine, and automation-enabled discovery platforms.

Australia supports protein engineering automation through biomedical research, vaccine development, agricultural biotechnology, and translational science networks, with emphasis on collaborative infrastructure and high-quality analytical capabilities. France combines strengths in biomedical research, immunology, structural biology, and industrial biotechnology, supporting automation in therapeutic protein development and functional screening. South Korea is advancing rapidly in biopharmaceutical manufacturing, cell and gene therapy research, synthetic biology, and smart laboratory infrastructure, making automated protein engineering workflows increasingly important for accelerating discovery and process development.

Italy and Spain are advancing life science research capacity in biopharmaceutical development, diagnostics, food biotechnology, and academic protein science, where automation helps improve throughput and reproducibility. Canada supports automation adoption through strengths in structural biology, protein science, AI research, and biomedical innovation, with growing emphasis on translational research and biomanufacturing readiness. Russia maintains activity in molecular biology, vaccine science, and biotechnology research, with automation adoption shaped by domestic research priorities and infrastructure modernization.

Brazil is an important Latin American center for agricultural biotechnology, vaccine research, public health science, and industrial bioprocessing, making automated protein engineering workflows relevant for enzymes, biologics, and diagnostic reagents. Mexico is expanding biotechnology and pharmaceutical research capacity, with automation adoption linked to academic modernization, diagnostics, and regional biomanufacturing development. Spain continues to strengthen automation-enabled life science capabilities through biomedical institutes, biotechnology clusters, and protein science research focused on reproducibility, assay quality, and translational applications.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize automation strategies that align scientific goals with data integrity, workflow scalability, and long-term interoperability. The first priority is to map the full protein engineering lifecycle, from sequence design and DNA assembly to expression, purification, assay development, characterization, and data analysis. This helps identify bottlenecks where automation can deliver the strongest operational and scientific value.

Organizations should adopt modular automation architectures that allow incremental scaling instead of rigid, single-purpose systems. Flexible liquid handlers, integrated plate logistics, automated incubators, microfluidic platforms, and connected analytical instruments can be combined based on evolving research needs. Investment in laboratory informatics is equally critical; electronic lab notebooks, laboratory information management systems, standardized metadata, and application programming interfaces should be treated as core infrastructure rather than optional add-ons.

To capture the full value of AI-enabled protein engineering, leaders should establish robust data governance, assay standardization, and model validation practices. High-throughput automation is most powerful when datasets are clean, contextualized, and comparable across experiments. Cross-functional teams that include protein scientists, automation engineers, data scientists, software specialists, and quality experts are essential for successful implementation.

Decision-makers should also focus on workforce development. Automated laboratories require personnel who understand both biological experimentation and system-level operations. Training programs should cover instrument scripting, troubleshooting, data management, experimental design, and quality control. Finally, leaders should evaluate automation investments not only by speed gains but also by reproducibility, reduced error rates, better sample traceability, improved data usability, and faster design-build-test-learn cycles.

Research Methodology

A robust research methodology for assessing lab automation in protein engineering should combine secondary research, expert validation, and structured analysis of scientific, technological, and regulatory developments. Secondary research involves reviewing peer-reviewed literature, patent publications, regulatory guidance, public research funding announcements, technical standards, conference proceedings, and institutional reports related to automated laboratory workflows, protein design, high-throughput screening, and AI-enabled biotechnology.

Primary validation should include discussions with domain specialists such as protein engineers, automation scientists, laboratory informatics experts, bioprocess development professionals, synthetic biology researchers, quality leaders, and academic investigators. These insights help verify adoption patterns, workflow challenges, technology readiness, and practical implementation barriers.

The analysis should evaluate technology categories including automated liquid handling, robotics, microfluidics, laboratory informatics, high-content and high-throughput screening, sequencing-integrated workflows, mass spectrometry automation, automated protein purification, and AI-supported design platforms. Regional and country-level insights should be assessed through publicly available research infrastructure indicators, biotechnology policy initiatives, academic output, clinical and translational research activity, and laboratory modernization programs.

To ensure analytical reliability, findings should be triangulated across multiple credible sources and reviewed for consistency. The methodology should avoid unverified assumptions and should focus on evidence-based trends, adoption drivers, operational barriers, regulatory considerations, and emerging use cases without relying on speculative market sizing or forecasting.

Conclusion

Lab automation in protein engineering is becoming a foundational capability for modern biotechnology, enabling faster experimentation, improved reproducibility, stronger data traceability, and more efficient protein optimization. As protein design challenges become more complex, laboratories are adopting integrated systems that connect robotics, high-throughput assays, laboratory informatics, and AI-driven design tools.

The most important shift is the movement toward closed-loop, data-centered experimentation. Automated platforms generate standardized experimental outputs, while computational models guide variant selection and accelerate learning across design-build-test-learn cycles. Regions and countries with strong biotechnology infrastructure, advanced research funding, skilled technical workforces, and supportive data governance practices are better positioned to capture the benefits of these systems.

For industry leaders, success depends on building automation strategies that are scientifically purposeful, digitally connected, and operationally scalable. Investments in modular platforms, interoperable data systems, workforce training, and AI-ready datasets will define competitive capability in protein engineering. As the field continues to evolve, automation will remain central to translating biological complexity into reliable, reproducible, and actionable innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Lab Automation in Protein Engineering Market, by Component

  • 7.1. Introduction
  • 7.2. Hardware
    • 7.2.1. Liquid Handling Systems
    • 7.2.2. Robotic Systems
    • 7.2.3. Automated Workstations
    • 7.2.4. Storage Systems
    • 7.2.5. Detection & Analysis Instruments
      • 7.2.5.1. Spectrophotometers
      • 7.2.5.2. Chromatography Systems
      • 7.2.5.3. Mass Spectrometry Systems
      • 7.2.5.4. Flow Cytometry Systems
    • 7.2.6. Microfluidics Systems
  • 7.3. Software
    • 7.3.1. Laboratory Information Management Systems
    • 7.3.2. Electronic Lab Notebooks
    • 7.3.3. Scheduling & Monitoring Software
  • 7.4. Services
    • 7.4.1. Installation Services
    • 7.4.2. Maintenance Services
    • 7.4.3. Training & Consulting Services

8. Lab Automation in Protein Engineering Market, by Protein Type

  • 8.1. Introduction
  • 8.2. Recombinant Proteins
  • 8.3. Monoclonal Antibodies
  • 8.4. Enzymes
  • 8.5. Peptides
  • 8.6. Fusion Proteins
  • 8.7. Membrane Proteins

9. Lab Automation in Protein Engineering Market, by Technology

  • 9.1. Introduction
  • 9.2. Acoustic Liquid Handling
    • 9.2.1. Piezoelectric Systems
    • 9.2.2. Ultrasonic Systems
  • 9.3. Magnetic Bead Separation
    • 9.3.1. Paramagnetic Beads
    • 9.3.2. Superparamagnetic Beads
  • 9.4. Microfluidics Systems
    • 9.4.1. Continuous Flow Systems
    • 9.4.2. Droplet Based Systems

10. Lab Automation in Protein Engineering Market, by Automation Level

  • 10.1. Introduction
  • 10.2. Fully Automated
  • 10.3. Semi Automated
  • 10.4. Manual Assisted

11. Lab Automation in Protein Engineering Market, by Deployment Mode

  • 11.1. Introduction
  • 11.2. On Premise
  • 11.3. Cloud Based
  • 11.4. Hybrid

12. Lab Automation in Protein Engineering Market, by Application

  • 12.1. Introduction
  • 12.2. Enzyme Engineering
    • 12.2.1. Directed Evolution
    • 12.2.2. Rational Design
  • 12.3. High Throughput Screening
    • 12.3.1. Lead Identification
    • 12.3.2. Lead Optimization
  • 12.4. Protein Expression Purification
    • 12.4.1. Chromatography
    • 12.4.2. Filtration
  • 12.5. Structure Analysis
    • 12.5.1. Nuclear Magnetic Resonance
    • 12.5.2. X Ray Crystallography

13. Lab Automation in Protein Engineering Market, by End User

  • 13.1. Introduction
  • 13.2. Academic & Research Institutes
  • 13.3. Biotechnology Companies
  • 13.4. Contract Research Organizations
  • 13.5. Pharmaceutical Companies

14. Lab Automation in Protein Engineering Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. Europe
  • 14.3. North America
  • 14.4. Latin America
  • 14.5. Africa
  • 14.6. Middle East

15. Lab Automation in Protein Engineering Market, by Group

  • 15.1. NATO
  • 15.2. G7
  • 15.3. BRICS
  • 15.4. European Union
  • 15.5. ASEAN
  • 15.6. GCC

16. Lab Automation in Protein Engineering Market, by Country

  • 16.1. China
  • 16.2. United States
  • 16.3. Japan
  • 16.4. India
  • 16.5. Germany
  • 16.6. United Kingdom
  • 16.7. Australia
  • 16.8. France
  • 16.9. South Korea
  • 16.10. Italy
  • 16.11. Canada
  • 16.12. Russia
  • 16.13. Brazil
  • 16.14. Mexico
  • 16.15. Spain

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. FPNV Positioning Matrix, 2025
  • 17.3. Market Concentration Analysis, 2025
    • 17.3.1. Concentration Ratio (CR)
    • 17.3.2. Herfindahl Hirschman Index (HHI)
  • 17.4. Recent Developments & Impact Analysis, 2025
  • 17.5. Product Portfolio Analysis, 2025
  • 17.6. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Agilent Technologies, Inc
  • 18.2. Amgen Inc
  • 18.3. Automata Technologies
  • 18.4. Becton Dickinson and Company
  • 18.5. Bio-Rad Laboratories Inc
  • 18.6. Bruker Corporation
  • 18.7. Codexis Inc
  • 18.8. Danaher Corporation
  • 18.9. Eppendorf SE
  • 18.10. F Hoffmann-La Roche Ltd
  • 18.11. Formulatrix Inc
  • 18.12. General Electric Company
  • 18.13. GenScript Biotech Corporation
  • 18.14. Gilson Inc
  • 18.15. Hamilton Company
  • 18.16. HighRes Biosolutions
  • 18.17. Hudson Robotics Inc
  • 18.18. Lonza Group AG
  • 18.19. Merck Healthcare KGaA
  • 18.20. Novo Nordisk AS
  • 18.21. PerkinElmer Inc
  • 18.22. QIAGEN NV
  • 18.23. Revvity Inc
  • 18.24. Sangamo Therapeutics Inc
  • 18.25. Siemens Healthineers AG
  • 18.26. Takara Bio Inc
  • 18.27. Tecan Group Ltd
  • 18.28. Thermo Fisher Scientific Inc
  • 18.29. Waters Corporation
  • 18.30. Zinsser North America

LIST OF FIGURES

  • FIGURE 1. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 27. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIQUID HANDLING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIQUID HANDLING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIQUID HANDLING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTIC SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTIC SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ROBOTIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATED WORKSTATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATED WORKSTATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATED WORKSTATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STORAGE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DETECTION & ANALYSIS INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DETECTION & ANALYSIS INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DETECTION & ANALYSIS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SPECTROPHOTOMETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SPECTROPHOTOMETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SPECTROPHOTOMETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CHROMATOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MASS SPECTROMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLOW CYTOMETRY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLOW CYTOMETRY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLOW CYTOMETRY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MICROFLUIDICS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MICROFLUIDICS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MICROFLUIDICS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LABORATORY INFORMATION MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LABORATORY INFORMATION MANAGEMENT SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LABORATORY INFORMATION MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ELECTRONIC LAB NOTEBOOKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ELECTRONIC LAB NOTEBOOKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ELECTRONIC LAB NOTEBOOKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SCHEDULING & MONITORING SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SCHEDULING & MONITORING SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SCHEDULING & MONITORING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INSTALLATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INSTALLATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INSTALLATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TRAINING & CONSULTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TRAINING & CONSULTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TRAINING & CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MONOCLONAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PEPTIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PEPTIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FUSION PROTEINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FUSION PROTEINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FUSION PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEMBRANE PROTEINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEMBRANE PROTEINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEMBRANE PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ACOUSTIC LIQUID HANDLING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ACOUSTIC LIQUID HANDLING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ACOUSTIC LIQUID HANDLING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PIEZOELECTRIC SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PIEZOELECTRIC SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PIEZOELECTRIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ULTRASONIC SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ULTRASONIC SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ULTRASONIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MAGNETIC BEAD SEPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MAGNETIC BEAD SEPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MAGNETIC BEAD SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PARAMAGNETIC BEADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PARAMAGNETIC BEADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PARAMAGNETIC BEADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SUPERPARAMAGNETIC BEADS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SUPERPARAMAGNETIC BEADS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SUPERPARAMAGNETIC BEADS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MICROFLUIDICS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MICROFLUIDICS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MICROFLUIDICS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CONTINUOUS FLOW SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONTINUOUS FLOW SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CONTINUOUS FLOW SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DROPLET BASED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DROPLET BASED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DROPLET BASED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL FULLY AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL FULLY AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FULLY AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SEMI AUTOMATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SEMI AUTOMATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SEMI AUTOMATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MANUAL ASSISTED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MANUAL ASSISTED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MANUAL ASSISTED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ON PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ON PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ON PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CLOUD BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CLOUD BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CLOUD BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HYBRID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HYBRID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HYBRID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ENZYME ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ENZYME ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ENZYME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL DIRECTED EVOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL DIRECTED EVOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL DIRECTED EVOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL RATIONAL DESIGN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL RATIONAL DESIGN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL RATIONAL DESIGN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HIGH THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HIGH THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HIGH THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL LEAD IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL LEAD IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL LEAD IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PROTEIN EXPRESSION PURIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL PROTEIN EXPRESSION PURIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL PROTEIN EXPRESSION PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL FILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL FILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL FILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL STRUCTURE ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL STRUCTURE ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL STRUCTURE ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL NUCLEAR MAGNETIC RESONANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL NUCLEAR MAGNETIC RESONANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL NUCLEAR MAGNETIC RESONANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL X RAY CRYSTALLOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL X RAY CRYSTALLOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL X RAY CRYSTALLOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DETECTION & ANALYSIS INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ACOUSTIC LIQUID HANDLING, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MAGNETIC BEAD SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MICROFLUIDICS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN EXPRESSION PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY STRUCTURE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DETECTION & ANALYSIS INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ACOUSTIC LIQUID HANDLING, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MAGNETIC BEAD SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MICROFLUIDICS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN EXPRESSION PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY STRUCTURE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DETECTION & ANALYSIS INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ACOUSTIC LIQUID HANDLING, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MAGNETIC BEAD SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MICROFLUIDICS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 230. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 232. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN EXPRESSION PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 234. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY STRUCTURE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DETECTION & ANALYSIS INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ACOUSTIC LIQUID HANDLING, 2018-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MAGNETIC BEAD SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 246. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MICROFLUIDICS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 248. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
  • TABLE 252. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN EXPRESSION PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY STRUCTURE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 254. LATIN AMERICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DETECTION & ANALYSIS INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ACOUSTIC LIQUID HANDLING, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MAGNETIC BEAD SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MICROFLUIDICS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN EXPRESSION PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY STRUCTURE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DETECTION & ANALYSIS INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ACOUSTIC LIQUID HANDLING, 2018-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MAGNETIC BEAD SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MICROFLUIDICS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 286. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 288. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
  • TABLE 290. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN EXPRESSION PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY STRUCTURE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 292. MIDDLE EAST LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. GLOBAL LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 294. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 295. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 296. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 297. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DETECTION & ANALYSIS INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 298. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 299. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 300. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 302. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ACOUSTIC LIQUID HANDLING, 2018-2032 (USD MILLION)
  • TABLE 303. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MAGNETIC BEAD SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 304. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MICROFLUIDICS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 305. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 306. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 307. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ENZYME ENGINEERING, 2018-2032 (USD MILLION)
  • TABLE 309. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
  • TABLE 310. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN EXPRESSION PURIFICATION, 2018-2032 (USD MILLION)
  • TABLE 311. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY STRUCTURE ANALYSIS, 2018-2032 (USD MILLION)
  • TABLE 312. NATO LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 314. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 315. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 316. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DETECTION & ANALYSIS INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 317. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 318. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 319. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 321. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY ACOUSTIC LIQUID HANDLING, 2018-2032 (USD MILLION)
  • TABLE 322. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MAGNETIC BEAD SEPARATION, 2018-2032 (USD MILLION)
  • TABLE 323. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY MICROFLUIDICS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 324. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 325. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 326. G7 LAB AUTOMATION IN PROTEIN ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 327. G7 LAB AUTOMATION IN PROTEIN ENGINEERI